Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disorder of the fetus or newborn that occurs when fetal cells that are coated with IgG alloantibodies from the mother attack antigens inherited from the father. Severity can range from absence of symptoms to death.
Biomarker and diagnostic research for fetal erythroblastosis has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
156 publications have been identified in PubMed for fetal erythroblastosis. Research spans Review / Meta-Analysis (33%), Epidemiology / Natural History (20%), and Clinical Trial Publication (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 52 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:03 PM UTC
Disease patterns and progression |
31 |
20% |
Clinical study results | 25 | 16% |
Patient case studies | 20 | 13% |
Laboratory research | 20 | 13% |
Testing and diagnosis research | 6 | 4% |
New treatment approaches | 2 | 1% |
Lai NM (2026). [PMID: 41784088](https://pubmed.ncbi.nlm.nih.gov/41784088/). *Cochrane Database Syst Rev*. [Review / Meta-Analysis]
Sarwar A (2026). [PMID: 32809323](https://pubmed.ncbi.nlm.nih.gov/32809323/). *Unknown Journal*. [Review / Meta-Analysis]
Campos-Aguirre E (2026). [PMID: 41417454](https://pubmed.ncbi.nlm.nih.gov/41417454/). *Rev Med Inst Mex Seguro Soc*. [Review / Meta-Analysis]
Nassar GN (2026). [PMID: 30020664](https://pubmed.ncbi.nlm.nih.gov/30020664/). *Unknown Journal*. [Review / Meta-Analysis]
Lange K (2026). [PMID: 41693223](https://pubmed.ncbi.nlm.nih.gov/41693223/). *Transfusion*. [Clinical Trial Publication]
Desalew A (2026). [PMID: 41406924](https://pubmed.ncbi.nlm.nih.gov/41406924/). *Best Pract Res Clin Obstet Gynaecol*. [Review / Meta-Analysis]
Ligthart PC (2026). [PMID: 41965234](https://pubmed.ncbi.nlm.nih.gov/41965234/). *Immunohematology*. [Review / Meta-Analysis]
Gulrajani NB (2026). [PMID: 41360703](https://pubmed.ncbi.nlm.nih.gov/41360703/). *Prenat Diagn*. [Epidemiology / Natural History]
de Winter DP (2026). [PMID: 41591368](https://pubmed.ncbi.nlm.nih.gov/41591368/). *NEJM evidence*. [Basic Science / Preclinical]
Bhardwaj G (2026). [PMID: 41965236](https://pubmed.ncbi.nlm.nih.gov/41965236/). *Immunohematology*. [Case Report / Case Series]